PAMGENE B.V.
Patent Owner
Stats
- 11 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 20, 2016 most recent publication
Details
- 11 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 352 Total Citation Count
- Sep 14, 1999 Earliest Filing
- 36 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9448237 Modified tyrosine amino acids, peptides containing them, and their use for detecting hydrolase enzyme activityMay 18, 12Sep 20, 16[C12Q, C07F, C07C, G01N, C07K]
9075061 Method for determining the estrogen receptor status of breast cancerApr 12, 10Jul 07, 15[C12Q, G01N, C40B]
8962267 Method for predicting the response of non-small cell lung cancer patients to targeted pharmacotherapyApr 12, 10Feb 24, 15[C12Q, G01N, C40B]
8962268 Method for determining survival prognosis of patients suffering from non-small cell lung cancer (NSCLC)Apr 12, 10Feb 24, 15[C12Q, G01N, C40B]
8617836 Method for predicting the response of locally advanced rectal cancer to chemoradiotherapyApr 12, 10Dec 31, 13[C12Q]
7473562 Method for high-throughput integrated chemical and biochemical reactionsJun 02, 03Jan 06, 09[G01N]
6383748 Analytical test device with substrate having oriented through going channels and improved methods and apparatus for using sameSep 14, 99May 07, 02[C12Q]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0342,931 METHOD FOR PREDICTING RESPONSE TO ENDOCRINE THERAPYAbandonedSep 14, 12Nov 20, 14[G01N]
2013/0217,055 METHOD FOR PREDICTING TYROSINE KINASE INHIBITOR (TKI) RESISTANCE IN PATIENTS SUFFERING FROM CHRONIC MYELOGENOUS LEUKEMIA (CML)AbandonedOct 17, 11Aug 22, 13[C12Q]
2012/0115,754 METHOD FOR DIAGNOSING AND/OR TYPING RENAL CELL CARCINOMAAbandonedApr 12, 10May 10, 12[C12Q, C40B]
2012/0035,076 IRAK KINASE FAMILY AS NOVEL TARGET AND BIOMARKER FOR ALZHEIMERAbandonedApr 26, 10Feb 09, 12[C12Q, C40B]
2012/0021,939 METHOD FOR PROFILING DRUG COMPOUNDS USING PROTEIN KINASE INHIBITORSAbandonedApr 12, 10Jan 26, 12[C40B]
2011/0071,052 MEASUREMENT OF PROTEIN KINASE ACTIVITY IN CEREBROSPINAL FLUID FOR DIAGNOSIS OF NEUROLOGICAL AND PSYCHIATRIC DISORDERSAbandonedApr 24, 09Mar 24, 11[C40B]
2010/0203,043 TREATMENT AND DIAGNOSIS OF METASTATIC PROSTATE CANCER WITH INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)AbandonedApr 11, 08Aug 12, 10[A61K, G01N, A61P]
2009/0203,543 Method for Assaying Enzyme Activity in Histological SampleAbandonedNov 10, 06Aug 13, 09[C12Q, G01N, C40B]
2009/0117,552 Method for Detection and Quantification of Target Nucleic Acids in a SampleAbandonedJul 05, 06May 07, 09[C12Q, C40B]
7504209 Method and device for integrated nucleic acid integrity assessment and analysisExpiredMar 01, 04Mar 17, 09[C07H, C12Q]
2009/0042,215 Cell Permeability Assay in a Living Array of Multiple Cell Types and Multiple Layers of a Porous SubstrateAbandonedMay 11, 05Feb 12, 09[C12M, G01N]
7419778 Method for high throughput cell-based assays using versatile living microarraysExpiredJun 03, 03Sep 02, 08[C12Q]
2008/0090,739 Masked Solid Porous Supports Allowing Fast And Easy Reagent Exchange To Accelerate Electrode-Based MicroarraysAbandonedSep 28, 05Apr 17, 08[C23C, C25D, C40B]
2007/0202,137 Device For Sensing Of Motile Living Organisms And Uses ThereofAbandonedApr 20, 05Aug 30, 07[A61K, A01N, C12M]
2007/0160,998 Device for analyzing an interaction between target and probe moleculesAbandonedFeb 08, 05Jul 12, 07[C12Q, C12M]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.